back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-28 20:52 Tx date 2024-03-28 |
$NGEN
NervGen Pharma Corp. |
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$38,298
+12,766 vol $3.00 each |
12,766 | |
| Filed 2024-03-28 20:51 Tx date 2024-03-28 |
$NGEN
NervGen Pharma Corp. |
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$60,000
+25,532 vol $2.35 each |
1,125,532 | |
| Filed 2024-02-27 01:05 Tx date 2024-02-22 |
$NGEN
NervGen Pharma Corp. |
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$100,000
+100,000 vol $1.00 each |
1,100,000 | |
| Filed 2024-02-27 00:29 Tx date 2024-02-22 |
$NGEN
NervGen Pharma Corp. |
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-100,000
-100,000 vol $1.00 each |
225,000 | |
| Filed 2023-05-25 12:21 Tx date 2023-05-23 |
$NGEN
NervGen Pharma Corp. |
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$80,500
+50,000 vol $1.61 each |
325,000 | |
| Filed 2023-02-28 20:51 Tx date 2023-02-28 |
$NGEN
NervGen Pharma Corp. |
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
47 - Acquisition or disposition by gift
|
-1,450,000 vol |
1,000,000 | |
| Filed 2023-02-24 14:32 Tx date 2023-02-22 |
$NGEN
NervGen Pharma Corp. |
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$48,500
+25,000 vol $1.94 each |
275,000 | |
| Filed 2022-11-17 16:58 Tx date 2022-11-15 |
$NGEN
NervGen Pharma Corp. |
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$87,000
+50,000 vol $1.74 each |
250,000 | |
| Filed 2022-04-27 20:02 Tx date 2022-04-26 |
$NGEN
NervGen Pharma Corp. |
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$160,000
+100,000 vol $1.60 each |
2,450,000 | |
| Filed 2022-04-27 19:51 Tx date 2022-04-26 |
$NGEN
NervGen Pharma Corp. |
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-160,000
-100,000 vol $1.60 each |
0 | |
| Filed 2022-04-27 19:47 Tx date 2022-04-26 |
$NGEN
NervGen Pharma Corp. |
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$160,000
+100,000 vol $1.60 each |
||
| Filed 2022-04-27 19:45 Tx date 2020-05-20 |
$NGEN
NervGen Pharma Corp. |
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+100,000 vol |
100,000 | |
| Filed 2022-04-27 19:43 Tx date 2017-01-19 |
$NGEN
NervGen Pharma Corp. |
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-09-14 18:15 Tx date 2021-09-13 |
$NGEN
NervGen Pharma Corp. |
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$105,000
+50,000 vol $2.10 each |
200,000 | |
| Filed 2021-09-13 21:22 Tx date 2021-09-12 |
$NGEN
NervGen Pharma Corp. |
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$105,000
+50,000 vol $2.10 each |
||
| Filed 2021-09-13 21:22 Tx date 2021-09-12 |
$NGEN
NervGen Pharma Corp. |
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$105,000
+50,000 vol $2.10 each |
200,000 | |
| Filed 2020-08-20 22:45 Tx date 2020-05-22 |
$NGEN
NervGen Pharma Corp. |
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$175,000
+100,000 vol $1.75 each |
2,350,000 | |
| Filed 2020-06-05 12:24 Tx date 2020-06-03 |
$NGEN
NervGen Pharma Corp. |
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$135,000
+50,000 vol $2.70 each |
150,000 | |
| Filed 2019-04-24 11:58 Tx date 2017-03-27 |
$RAUH
Regency Gold Corp. |
Punnett, Harold
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,000 | ||
| Filed 2017-03-27 16:58 Tx date 2017-03-27 |
$RAUH
Regency Gold Corp. |
Punnett, Harold
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2009-01-02 16:15 Tx date 2008-03-08 |
$RAUH
Regency Gold Corp. |
Punnett, Harold
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-03-10 Tx date 2019-01-17 |
$
NervGen Pharma Corp. |
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$100,000
+100,000 vol $1.00 each |
100,000 | |
| Filed 2019-03-10 Tx date 2018-06-11 |
$
NervGen Pharma Corp. |
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$12,499
+1,249,999 vol $0.01 each |
1,250,000 | |
| Filed 2019-03-10 Tx date 2017-01-19 |
$
NervGen Pharma Corp. |
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-03-10 Tx date 2017-01-19 |
$
NervGen Pharma Corp. |
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1 | ||
| Filed 2019-03-10 Tx date 2018-06-19 |
$
NervGen Pharma Corp. |
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$200,000
+1,000,000 vol $0.20 each |
2,250,000 | |
| Filed 2017-03-29 Tx date 2008-03-08 |
$RAUH
Regency Gold Corp. |
Punnett, Harold
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-29 Tx date 2017-03-27 |
$RAUH
Regency Gold Corp. |
Punnett, Harold
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-29 Tx date 2017-03-27 |
$RAUH
Regency Gold Corp. |
Punnett, Harold
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-29 Tx date 2017-03-27 |
$RAUH
Regency Gold Corp. |
Punnett, Harold
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-27 Tx date 2008-03-08 |
$RAUH
Regency Gold Corp. |
Punnett, Harold
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-27 Tx date 2017-03-27 |
$RAUH
Regency Gold Corp. |
Punnett, Harold
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-27 Tx date 2017-03-27 |
$RAUH
Regency Gold Corp. |
Punnett, Harold
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
75,000 | ||
| Filed 2017-03-27 Tx date 2017-03-27 |
$RAUH
Regency Gold Corp. |
Punnett, Harold
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-27 Tx date 2008-03-08 |
$RAUH
Regency Gold Corp. |
Punnett, Harold
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|